|
Other anticoagulants
Citations 1-10 of 33 total displayed.
|
Most recent content
(1 Dec 2009):
|
- Original Contributions
Ancrod in Acute Ischemic Stroke: Results of 500 Subjects Beginning Treatment Within 6 Hours of Stroke Onset in the Ancrod Stroke Program
- David E. Levy, Gregory J. del Zoppo, Bart M. Demaerschalk, Andrew M. Demchuk, Hans-Christoph Diener, George Howard, Markku Kaste, Arthur M. Pancioli, Carmen Spatareanu, and Warren W. Wasiewski
Stroke 2009;40:3796-3803; published online before print as doi:10.1161/STROKEAHA.109.565119
[Abstract]
[Full text]
|
Past content
(since Nov 2000):
|
- Articles
Ancrod in Acute Ischemic Stroke. Results of 500 Subjects Beginning Treatment Within 6 Hours of Stroke Onset in the Ancrod Stroke Program
- David E. Levy, Gregory J. del Zoppo, Bart M. Demaerschalk, Andrew M. Demchuk, Hans-Christoph Diener, George Howard, Markku Kaste, Arthur M. Pancioli, Carmen Spatareanu, and Warren W. Wasiewski
Stroke published October 29, 2009, doi:10.1161/STROKEAHA.109.565119
[Abstract]
- Cochrane Corner
Anticoagulants for Acute Ischemic Stroke
- Peter Sandercock, Carl Counsell, and Ayeesha K. Kamal
Stroke 2009;40:e483-484e; published online before print as doi:10.1161/STROKEAHA.108.538157
[Full text]
- Articles
Anticoagulants for Acute Ischemic Stroke
- Peter Sandercock, Carl Counsell, and Ayeesha K. Kamal
Stroke published May 21, 2009, doi:10.1161/STROKEAHA.108.538157
[Abstract]
- Original Contributions
Failure of Antithrombotic Therapy and Risk of Stroke in Patients With Symptomatic Intracranial Stenosis
- Tanya N. Turan, Lucian Maidan, George Cotsonis, Michael J. Lynn, Jose G. Romano, Steven R. Levine, Marc I. Chimowitz for the WASID Investigators
Stroke 2009;40:505-509; published online before print as doi:10.1161/STROKEAHA.108.528281
[Abstract]
[Full text]
- Articles
Failure of Antithrombotic Therapy and Risk of Stroke in Patients With Symptomatic Intracranial Stenosis
- Tanya N. Turan, Lucian Maidan, George Cotsonis, Michael J. Lynn, Jose G. Romano, Steven R. Levine, Marc I. Chimowitz for the WASID Investigators
Stroke published December 18, 2008, doi:10.1161/STROKEAHA.108.528281
[Abstract]
- Original Contributions
Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk: The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W)
- Jeff S. Healey, Robert G. Hart, Janice Pogue, Marc A. Pfeffer, Stefan H. Hohnloser, Raffaele De Caterina, Greg Flaker, Salim Yusuf, and Stuart J. Connolly
Stroke 2008;39:1482-1486; published online before print as doi:10.1161/STROKEAHA.107.500199
[Abstract]
[Full text]
- Cochrane Corner
Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No History of Stroke or Transient Ischemic Attacks
- Maria I. Aguilar and Robert Hart
Stroke 2008;39:1399-1400; published online before print as doi:10.1161/STROKEAHA.107.500363
[Full text]
- Articles
Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No History of Stroke or Transient Ischemic Attacks
- Maria I. Aguilar and Robert Hart
Stroke published March 6, 2008, doi:10.1161/STROKEAHA.107.500363
[Abstract]
- Articles
Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk. The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W)
- Jeff S. Healey, Robert G. Hart, Janice Pogue, Marc A. Pfeffer, Stefan H. Hohnloser, Raffaele De Caterina, Greg Flaker, Salim Yusuf, and Stuart J. Connolly
Stroke published March 6, 2008, doi:10.1161/STROKEAHA.107.500199
[Abstract]
|
|
